Transformed cells express high levels of non-telomeric reverse-transcriptase (RT) activity of retrotransposon and endogenous retrovirus origin. We previously reported that RT inhibition, either pharmacological or through transient silencing of RT-encoding LINE-1 (L1) elements by RNA interference (RNAi), reduced proliferation, induced differentiation and reprogrammed gene expression in human tumorigenic cell lines. Moreover, the antiretroviral drug efavirenz antagonized tumor progression in animal models in vivo. To get insight into the role of retroelements in tumorigenesis, we have now produced two cell lines derived from A-375 melanoma, in which the expression of either L1 retrotransposon, or HERV-K endogenous retrovirus, was stably suppressed by RNAi. Compared to the parental A-375 cell line, cells with stably interfered L1 expression show a lower proliferation rate, a differentiated morphology and lower tumorigenicity when inoculated in nude mice. L1 silencing modulates expression of several genes and, unexpectedly, also downregulates HERV-K expression. In HERV-K interfered cells, instead, L1 expression was unaffected, and cell proliferation and differentiation remained unchanged compared to parental A-375 cells. In vivo, however, their tumorigenic potential was found to be reduced after inoculation in nude mice. These results suggest that L1 and HERV-K play specific and distinct roles in cell transformation and tumor progression.
Introduction
Retroelements, including non-LTR retrotransposons and endogenous retroviruses (ERVs), are genetic elements that spread in eukaryotic genomes by replicating through RNA intermediates. Owing to the lack of any obvious function, these elements have been traditionally regarded as parasitic components of genomes (Orgel and Crick, 1980) . More recently, however, this view has been challenged on essentially two grounds, a structural and a functional one. First, sequencing of higher eukaryotic genomes, that was relentlessly accomplished in the last few years, indicates that large portions of the genome are constituted by retroelements, whereas protein-encoding host genes do not exceed a mere 1-2% (45 and 1.2% in the human genome, respectively) (International Human Genome Consortium, 2001; Batzer and Deininger, 2002) . These unexpected results raised the question of why genomes replicate and maintain such a huge amount of parasitic burden throughout evolution, if devoid of any role. Second, retroelements have been recently reconsidered in a 'functionalist' perspective (Kazazian, 2004; Han and Boeke, 2005 ; for a review see Shapiro and von Sternberg, 2005) , supported by experimental data that show that these repeated element families are indeed endowed with functional and structural roles in various normal and pathological processes.
In line with these views, we have recently shown that LINE-1 (L1)-encoded reverse-transcriptase (RT) plays a key role in early embryonic development Beraldi et al., 2006) and in tumorigenesis (Mangiacasale et al., 2003; Landriscina et al., 2005; Sciamanna et al., 2005 ; reviewed by Sinibaldi-Vallebona et al., 2006) . More specifically, we have found that pharmacological inhibition of endogenous RT using either nevirapine or efavirenz, two non-nucleosidic RT inhibitors widely used in AIDS treatment, reduces cell proliferation and promotes differentiation in human tumorigenic cell lines (Mangiacasale et al., 2003; Landriscina et al., 2005) . Similar effects were induced following downregulation of L1 expression by transient RNA interference (RNAi) (Sciamanna et al., 2005) . Indeed, changes in cell fate observed after inhibition of RT activity by either antiretroviral drugs or by RNAi are accompanied by a reprogramming of gene expression. From these data, the cellular endogenous RT emerges as a constitutive functional component in tumorigenic cells characterized by a high proliferation and a low differentiation status. Furthermore, our data support the conclusion that high expression of L1 elements and activity of the RT which they encode, are among causative agents, rather than the consequence, of the undifferentiated state.
Here, we take one step further and show that constructs expressing L1-or HERV-K-targeted siRNA delivered to human melanoma cells via infection via a retroviral vector cause long-lasting interference effects. Under these conditions, cultured cells defective for L1 expression exhibit typical features of differentiating cells, and when inoculated into nude mice, a markedly reduced in vivo tumorigenicity compared to non-interfered cells. In contrast, silencing of HERV-K expression had no visible effect on cell growth in vitro, but caused a reduced tumorigenicity upon inoculation in nude mice, similar to L1-interfered cells. These results support the conclusion that these two families of retroelements play functional and distinct roles in the onset and progression of the tumorigenic process.
Results
Expression of L1 ORF1 and ORF2 is reduced in human A-375 melanoma cells infected with a retroviral vector expressing L1-specific siRNA We have reported previously that transient transfection of A-375 melanoma cells with siRNA oligonucleotides targeted against a highly expressed human L1 retrotransposon, reduced the rate of cell proliferation and promoted differentiation (Sciamanna et al., 2005) . We have now investigated the response of these cells after silencing, or efficiently downregulating L1 activity by stable RNAi. To this end, A-375 cells were infected with a retroviral vector containing the construct, expressing a 19 bp double-stranded RNA oligonucleotide directed against the ORF1-coding region of functional human L1 elements pS-L1i (Figure 1a ) (Brouha et al., 2003) . The effectiveness of interference against L1 expression compared to control cells infected with empty vector (pS-neo) was assessed by immunofluorescence (IF), RT-PCR and immunoblotting analyses. Figure 2A shows an IF assay using an antibody (anti-L1EN), raised against polypeptides encoded by the endonuclease (EN)-domain of L1 ORF2 (Ergun et al., 2004) , in A-375 cells infected with either vector alone (pS-neo), or with L1-interfering construct (pS-L1i). In control (pS-neo) cells, the L1-encoded protein exhibits a discrete localization, close or adjacent to the nuclear envelope (panels a and b); in contrast, no signal is detected in the pS-L1 interfered cells (panels c and d). Western blot analysis ( Figure 2B ) revealed the full-length protein (150 kDa) encoded by L1 ORF2, as well as lower molecular weight protein species, as expected (Ergun et al., 2004) . Roles of LINE-1 and HERV-K in tumorigenesis E Oricchio et al relative to tubulin signals confirmed a drastic reduction (about 80%) of L1-encoded proteins in interfered (pS-L1i) compared to control (pS-neo) cell extracts ( Figure 2C ). RT-PCR revealed a comparable reduction at the mRNA level with ORF1-and ORF2-specific primers in pS-L1i-infected, but not in pS-neo-infected cells ( Figure 2D ).
We next evaluated the expression of HERV-K in L1-interfered versus non-interfered cells. High HERV-K expression levels are reported to be a specific feature of human melanoma cells (see Humer et al., 2006 and references therein) . Given that pharmacological RT inhibitors (Mangiacasale et al., 2003; Landriscina et al., 2005; Sciamanna et al., 2005) , and L1-targeted RNAi (Sciamanna et al., 2005) , consistently reprogram the expression of a variety of protein-encoding genes, we wondered whether HERV-K-encoded genes are also affected. Figure 2D shows that expression of HERV-Kencoded pol and env genes is indeed considerably reduced in pS-L1i compared to control pS-neo cells. The 19-bp oligonucleotide used to target L1 expression maps to the L1-ORF1 coding region and shares no homology with the HERV-K sequence; this rules out the possibility that the downregulation of HERV-K observed in our experiments reflects a cross-interference effect. These results indicate that not only protein-encoding genes, but also retroelements are modulated by L1 expression levels.
A-375 cells expressing a LINE-1-targeting RNAi construct exhibit a stable reduction of proliferation as well as induction of differentiation Changes in cell morphology and proliferation rate were analysed in L1-interfered (pS-L1i), vector-infected (pSneo-infected) and in non-infected A-375 cells at days 16, 23 and 33 after infection. Cell counts recorded in noninfected parental cultures were set as 100%. As shown in Figure 3a , proliferation progressively decreased in pSL1i-infected cell cultures (grey bars) and was reduced to 30% of the initial rate at day 33 after infection; during this time, pS-neo-infected cells (white bars) exhibited a modest decrease of proliferation to about 70% during the early-and mid-phases of interference. However, in the latest phase, pS-neo infected cells resumed the original high proliferation rate, which is identical to the rate of non-infected control cells (black bars). pS-L1i-interfered cells underwent progressive morphological changes, characterized by a star-shaped morphology with dendritic-like extensions, differing substantially from the rounded shape of both untreated and pSneo-infected A-375 cells ( Figure 3b ). This is suggesting that a differentiation process has been activated. These results support the conclusion that stable L1-targeted RNAi reduces proliferation and promotes differentiation in A-375 melanoma cells.
To investigate further the molecular features of this phenomenon, we analysed the expression of five known regulators of proliferation and differentiation ( Figure 3c ). Cyclin D1 and c-myc were analysed as proliferation markers (Sauter et al., 2002; Ross et al., 2006) , mda-7 and a-5 integrin as differentiation markers and gapdh as a housekeeping gene serving as a reference in RT-PCR assays. Consistent with our previous observations in transiently interfered cells (Sciamanna et al., 2005) , the expression of cyclin D1 and c-myc is downregulated in L1 stably interfered cells. Consistent with our prediction, the differentiation markers respond variably to L1 RNAi: a-5 integrin, whose expression positively correlates with melanoma metastatic progression (Quia et al., 2005) , is downregulated after L1 RNAi; in contrast, mda-7, whose expression increases during induction of terminal differentiation while being expressed at low levels, if at all, in tumor cells (Dent et al., 2005) , is upregulated ( Figure 3c ).
A-375 cells stably interfered for HERV-K expression exhibit distinct features from those induced by L1 interference We next sought to investigate whether HERV-K has also a role in the mechanism controlling cell proliferation and differentiation. A-375 cells were infected with a retroviral vector expressing a 19-bp HERV-K targeted RNAi oligonucleotide pS-H-Ki (see Figure 1b) . IF assays using an antibody directed against HERV-Kencoded env ( Figure 4A ) depicted a broad distribution of this protein in both the cytoplasmic and nuclear 
Roles of LINE-1 and HERV-K in tumorigenesis
E Oricchio et al compartments in control pS-puro-infected A-375 cells (panels a and b), whereas no signal was detected in interfered pH-Ki cells (panels c and d). Interestingly, HERV-K env protein is also undetectable in pS-L1i cells ( Figure 4B , panels a and b), which is consistent with the observation that the inhibition of L1 expression yields a downregulation of HERV-K transcript levels ( Figure 2D ). In contrast, L1-encoded protein expression remains unchanged in pS-H-Ki cells ( Figure 4B , panels c and d). RT-PCR experiments further confirmed that transcription of both HERV-K POL and ENV was repressed in pS-H-Ki cells ( Figure 4C ). Different from the phenotypes observed in pS-L1i cells, HERV-K interference did neither affect the expression of L1 ORF1, which remained stable in pS-puro-and pS-H-Ki cells, nor that of mda-7 or a-integrin genes. In sharp contrast to L1 interference, HERV-K interference yielded only modest effects on cell proliferation ( Figure 4D ) and no effect on differentiation at all ( Figure 4E) ; indeed, the rate of cell proliferation in pS-H-Ki cultures (blue bars) remained stable over time and ranged as high as 70-80% of pS-puro-infected (yellow bars) and non-infected (purple bars) control cultures. Furthermore, the morphology of pS-H-Ki is indistinguishable from that of non-interfered pS-puro cells ( Figure 4E ), indicating that no differentiation process was triggered.
A-375 cells interfered for L1 or HERV-K have a reduced tumorigenicity compared to control cells
The finding that downregulation of L1 or HERV-K activity differently affect critical features of A-375 melanoma cells, including proliferation and differentiation, prompted us to investigate the tumorigenic potential of stably interfered cell lines for each of these two retroelements. To this end, five groups of athymic nude mice were subcutaneously inoculated in the limb with (a) parental non-infected A-375 cells, or with (b) pS-neo empty vector, (c) pS-scrambled (non-specific oligonucleotide), (d) pS-H-Ki and (e) pS-L1i infected A-375 cells. Tumor progression was monitored by determining the tumor volume at regular intervals after inoculation. As shown in Figure 5 , tumor growth was markedly reduced using both retroelement-interfered cell lines, that is, pS-H-Ki (yellow curve) and pS-L1i (light blue curve), compared to both non-infected (CTR, blue curve) and pS-neo-infected (purple curve) A375 cells. The curve obtained for pS-scrambled did completely overlap with that of pS-neo and is not shown in the figure. Some slight difference was observed between the two retroelement-interfered cell lines, with pS-L1i being somewhat less tumorigenic compared to pS-H-Ki. These results show that, in spite of the fact that HERV-K interference did not substantially affect important parameters in cell proliferation or differentiation in culture, it significantly reduced the tumorigenic potential of A-375 cells in vivo.
Discussion
The results presented in this work demonstrate that the activity of the retroelements L1 and HERV-K play distinct roles in tumorigenesis and tumor progression. Evidence supporting this conclusion emerges from the generation of two stable A-375 human melanoma- Roles of LINE-1 and HERV-K in tumorigenesis E Oricchio et al derived cell lines, in which the expression of either L1 or HERV-K retroelements was stably downregulated using specific RNAi-expressing constructs delivered to cells via infection with a retroviral vector. Compared to the parental A-375 cells, the functional features of the stably interfered cell lines reveal that L1 and HERV-K are both implicated in a molecular mechanism controlling cell growth and tumorigenesis and disclose distinct aspects underlying this mechanism. First, the functional knockdown of L1 expression in pS-L1i-infected cells also yielded the downregulation of HERV-K expression (Figure 2 ). In contrast, L1 expression remained unaffected in HERV-K interfered cells (pS-H-Ki), (Figure 4 ). This circumstance suggests that (i) different families of retroelements are not independent entities, but are linked in a functional network, and (ii) such functional network is organized in a hierarchical order, such that a one-way control mechanism flows from L1 to HERV-K expression but does not feedback in the reverse direction. In our previous work, we reported the intrinsic ability of L1 retrotransposons to modulate the expression of protein-encoding genes (Mangiacasale et al., 2003; Sciamanna et al., 2005;  reviewed by Sinibaldi-Vallebona et al., 2006) . The present results add the novel information that not only the expression of protein-encoding genes, but also that of other retroelement families, are influenced by L1. 
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Figure 4 Localization of HERV-K-ENV and effect of its downregulation in A-375 cells. (A) Immunostaining of endogenous HERV-K ENV proteins (red) in A-375 pS puro (a and b) and pS-H-Ki (c and d) cells using an antibody directed against HERV-K env (antienv). (B) Immunostaining of pS-L1i-and pS-H-Ki-infected cells with anti-ENV (a and b) and anti L1-EN (c and d) antibody (red).
Nuclear DNA was counterstained with DAPI (blue). Bar, 10 mm. 
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Second, L1-and HERV-K-interfered cell lines exhibit different functional features in cultured cells: the stable inactivation of L1 expression in pS-L1i cells yielded an A-375 derivative with a reduced proliferation rate, typical signs of morphological differentiation, and reprogrammed patterns of expression of key genes encoding differentiation markers. In contrast, the inactivation of HERV-K expression in the pS-H-Ki cell line did not cause any obvious effect in cell culture, such that these cells seem to be functionally and morphologically indistinguishable from the parental non-interfered A-375 cell line. Additionally, HERV-K interference does not seem to affect the original A375 cell line-specific expression profile of the panel of analysed genes.
Remarkably, in spite of the differential response of cells to retroelement-directed RNAi in culture conditions, both stably interfered cell lines display reduced tumorigenicity in vivo, as indicated by their lowered potential to develop tumors after inoculation in nude mice ( Figure 5 ). These results suggest that both retroelement families play significant roles at some step in the process of tumor growth, and yet their specific contribution to the mechanisms underlying the reduced tumorigenicity must be very different.
Indeed, the finding that stable interference with L1 expression in the pS-L1i cell line is associated with a lowered tumorigenic potential in vivo, compared to parental A-375 cells, is coherent and fully consistent with the observation that downregulation of L1 induces differentiation and reduces proliferation in this cell line in culture. The reduced tumorigenicity following inactivation of HERV-K expression must instead have a different explanation, because downregulation of HERV-K neither affects the level of differentiation nor the proliferative potential of A-375 cells in culture. In our view, the reduced tumorigenicity of HERV-K stably interfered cells (pS-H-Ki) might well reflect the immunosuppressive effect exerted by env expression in growing tumors. It has been clearly shown that expression of env, either encoded from infectious retroviruses (Mangeney and Heidmann, 1998; Blaise et al., 2001) or from endogenous retroviral elements (Mangeney et al., , 2005 , can subvert the immune surveillance system in mice, thereby eluding the rejection of tumors in immunocompetent animal models. The reduced tumorigenic ability of cells in which HERV-K expression is stably inactivated could be easily explained by envisaging that HERV-K-encoded env protein plays a similar immunosuppressive role, including in nude mice, which do in fact maintain a low level of immunosuppressive activity (Hasui et al., 1989; Farag and Caligiuri, 2006) . Our results suggest that L1 expression has a predominant role in early stages of tumorigenesis, possibly exerted by setting up favorable gene expression profiles for tumor growth, whereas HERV-K expression may favor tumor progression by reducing the immune surveillance of mice.
Consistent with the different functional roles of the two retroelement families in the process of tumorigenesis, L1-and HERV-K-encoded proteins exhibit a very different subcellular localization within tumor cells. In IF assays, L1-encoded proteins have a well-defined, sharp localization close, or adjacent, to the nuclear membrane (Figure 2A ). In contrast, HERV-K has a diffuse pattern throughout the nucleus and the cytoplasm ( Figure 4A ). The localization of L1 proteins is reminiscent of that of the nuclear lamina (Nickerson et al., 1997; see Gruenbaum et al., 2003 for review) . A wealth of evidence indicates the essential role of lamin proteins, and the nuclear lamina structure which they form, in control of fundamental functions, including the organization and positioning of active and nonexpressed chromatin, gene regulation, nuclear architecture and differentiation (reviewed by Goldman et al., 2002; Gruenbaum et al., 2003 Gruenbaum et al., , 2005 . It is tempting to speculate that L1-encoded proteins, especially L1-RT, participate in or interact with the nuclear lamina structure and, as such, exert their regulatory function on gene expression.
In conclusion, L1 and HERV-K are components of a retroelement-mediated network playing distinct, but integrated, roles in the process of cell transformation and tumorigenicity.
Materials and methods
Cell culture
Human A-375 melanoma (ATCC-CRL-1619) cells were seeded in six-well plates at a density to 5 Â 10 4 cells/well and cultured in Dulbecco's modified Eagle's medium (DMEM) with 10% fetal bovine serum. Cells were harvested every 96 h, counted in a Burker chamber (two countings/sample) and replated at the same density. Phoenix retrovirus-producing cells were purchased from ATCC and grown in DMEM supplemented with 10% fetal bovine serum, 2 mM L-glutamine and antibiotics. Cells were routinely maintained in humidified incubator at 371C and 5% CO 2 .
Assembly of the retroviral delivery vector and cell infection
To generate the L1 interfering construct pS-L1i, the 19-bp L1-targeted siRNA double-stranded oligonucleotide GA-GAACGCCACAAAGATAC was designed to target specifically the sequence 1492-1511 of active L1 elements as described (see supporting information Figure 6b in Brouha et al., 2003) . The 19-bp L1-specific oligonucleotide and a 17-bp scrambled oligonucleotide (GATCCCCTTTTTGGAAA) as control were inserted into the pS-neo/EGFP vector (Oligoengine, Seattle, WA, USA, PRT-0006), previously digested with BglII and HindIII restriction enzymes, generating pS-L1i and pS-scrambled constructs, respectively. To generate the HERV-K-interfering construct pS-H-Ki, the 19-bp HERV-K-siRNA double-stranded oligonucleotide TCCCAGTAACGTTA GAACC was designed to target the sequence 1877-1896 of HERV-K (accession number AF164614) within the GAG gene. The oligonucleotide was inserted into the pS-puro vector (Oligoengine, PRT-0002) after BglII and HindIII restriction.
Phoenix packaging cells (6 Â 10 5 ) were seeded 24 h before transfection. Cells were lipofected (Lipofectamine Reagent, GibcoBRL, San Giuliano Milanese, Italy, 18324-012) with 2 mg of DNA of the pS-L1i, pS-H-Ki, pS-neo, pS-puro and pS-scrambled constructs, following the manufacturer recommendations. Cell culture supernatants were collected 48 h after transfection and filtered through 0.45 mm filter. A-375 cells were infected for 12 h with the supernatants in the presence of 4 mg/ml polybrene (Sigma, Milano, Italy). The medium was then replaced with fresh virus-free medium. Cells were selected for pS-puro and pS-H-Ki infection in the presence of puromycin (Sigma, 0.5 mg/ml) for 48 h. pS-neo, pS-L1i and pS-scrambled infected cells were selected for resistance to G418 (Invitrogen, San Giuliano Milanese, Italy, 600 mg/ml) for 7 days. Infected cells were continuously maintained in culture with puromycin (0.2 mg/ml) or G418 (200 mg/ml), respectively. Cells were harvested every 96 h, counted in a Burker chamber (2 countings/sample) and replated at the same density.
Indirect immunofluorescence
Cells were grown on glass slides and permeabilized with CSK I buffer (0.5% Triton-X-100, 10 mM PIPES, 100 mM KCl, 300 mM sucrose, 1 mM EGTA, 3 mM MgCl 2 ) for 8 min and fixed with 4% paraformaldehyde for 10 min. Fixed cells were preincubated in 20% goat serum for 30 min at 371C in a humidified chamber and incubated for 1 h with chicken polyclonal anti L1-EN antibody (Ergun et al., 2004; 1:40 dilution) or with rabbit anti-env HERV-K antibody (1:70 dilution; Austral Biologicals, San Ramon, CA, USA). After three washes in phosphate-buffered saline (PBS) containing 0.05% Tween-20, cells were incubated with rhodamineconjugated anti-chicken or anti-rabbit antibody (1:600 dilution; Jackson Immunoresearch Laboratories, Westgrove, PA, USA, JIR). Nuclei were stained with 0.1 mg/ml 4,6-diamidino-2-phenylindole (DAPI). After washing in PBS, glass slides were mounted in Vectashield (Vector Laboratories, Segrate, Italy). Cell preparations were examined under a microscope (Leica, Milano, Italy, TCS4D) configured for epifluorescence and equipped with a cooled camera (Coolsnap).
Semiquantitative RT-PCR RNA extraction and treatment with RNase-free DNase I were performed as described . cDNAs were synthesized using 250 ng of polyA RNA, oligo (dT) and the Thermoscript system (Invitrogen) in reaction mixtures of 20 ml. A total of 2 ml from each reaction were amplified using the Platinum Taq DNA Polymerase kit (Invitrogen) and 30 pmol of specific oligonucleotides (MWGBiotech, Ebersberg, Germany) in a 2-min step at 941C followed by cycles of 30 s at 941C, 30 s at 54-581C and 1 min at 721C. Each pair of oligonucleotides was used in sequential amplification series with increasing numbers (25-31) of cycles. PCR products were fractionated on agarose gels, transferred to nylon membranes and hybridized for 16 h at 421C with [ Western blot analysis A-375 cells were harvested in PBS with 0.1 mM PMSF and lysed in TRIZOL (Invitrogen) supplemented with protease inhibitors (1 mM pepstatin, 1 mM leupeptin, 0.1 mM PMSF). Protein concentrations were determined using the Coomassie colorimetric assay (Pierce, Pero, Italy). Samples (20 mg) were fractionated on NuPAGE Novex 10% Bis-Tris gel (Invitrogen), transferred onto nitrocellulose membranes and processed for immunoblotting using chicken polyclonal anti L1-EN antibody (1:40 dilution) (Ergun et al., 2004) or mouse anti-atubulin (1:1000) (Sigma, T5168). HRP-conjugated anti-chicken IgY (Jackson Immunoresearch Laboratories, 703-035-155) or HRP-conjugated anti-mouse (Biorad, Segrate, Italy, 170-6516) secondary antibodies were used and signals were visualized using the enhanced chemiluminescence system (ECL Plus; Amersham Biosciences, Piscataway, NJ, USA).
Tumor xenografts and treatment of animals Five-week-old athymic nude mice (Harlan, Italy) were inoculated subcutaneously with A-375 melanoma, A-375 pSneo, A-375 pS-scrambled, A-375 pS-L1i and A-375 pS-H-Ki cells in 100 ml PBS. Tumor growth was monitored every other day by caliper measurement. Tumor volumes were calculated using the formula length Â width Â height (Umekita et al., 1996) . All animals were maintained in accordance with the European Union guidelines.
